Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02953782
Title Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Forty Seven, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Los Angeles California 90404 United States Details
Stanford University Palo Alto California 94305-5757 United States Details
Wayne State University Detroit Michigan 48201 United States Details
START Midwest Grand Rapids Michigan 49503 United States Details
UPENN Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Md Anderson Houston Texas 77030 United States Details
START Center for Cancer Care San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field